Jonas Karl Hansson
Chairman at Tribune Therapeutics AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Björn Ingemar Odlander | M | 66 |
HealthCap Advisor AB
 HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden.
Tribune Therapeutics AB
 Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | - |
| Georg Beiske | M | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | 5 years |
| Ole Kaasbøll | M | - |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | 4 years |
| Marten Steen | M | 49 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 14 years |
| CARL KILANDER | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 5 years |
| Elin Kristina Ekberg | F | 46 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 3 years |
| Elias Papatheodorou | M | 55 |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | - |
| Niklas Dahl | M | - |
University of Uppsala
| 24 years |
| Johan Olof Kämpe | M | 68 |
University of Uppsala
| 25 years |
| Oern Stuge | M | 70 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 15 years |
| Per-Olof Eriksson | M | 86 |
HealthCap Advisor AB
HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | - |
| Jacob Uno Stanley Gunterberg | M | 57 |
HealthCap Advisor AB
HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | - |
| Fredrik Skoglund | M | - |
FE Fonder AB
 FE Fonder AB Investment ManagersFinance FE Fonder AB is a private company based in Stockholm, Sweden. The Swedish company's expertise lies in the field of fund management, making them an ideal external resource for market and distribution. | 2 years |
| Mikael Löfdahl | M | - |
FE Fonder AB
FE Fonder AB Investment ManagersFinance FE Fonder AB is a private company based in Stockholm, Sweden. The Swedish company's expertise lies in the field of fund management, making them an ideal external resource for market and distribution. | 2 years |
| Milla Maria Koistinaho | M | - |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | - |
| Jørgen Søberg Petersen | M | - |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | - |
| João Ribas | M | - |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | - |
| Frans Gustaf Wuite | M | 64 |
HealthCap VII GP SA
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gunilla Lundmark | F | 61 |
University of Uppsala
| 2 years |
| Anders Martin-Löf | M | 53 | 3 years | |
| Christopher Drewsen | M | - |
Stockholm School of Economics
| 6 years |
| Louise Kores | F | - |
Stockholm School of Economics
| 6 years |
| Dan Parksjo | M | - |
Stockholm School of Economics
| 6 years |
| Johanna Sofia von Schéele | F | 37 |
Stockholm School of Economics
| 5 years |
| Bali Muralidhar | M | 44 | 4 years | |
| Charlotta Göransson | M | 52 |
University of Uppsala
| 5 years |
| Christine Ahlstrand | F | 38 |
Stockholm School of Economics
| 5 years |
| Fanny Leksell | F | - |
Stockholm School of Economics
| 5 years |
| Birgitte Volck | M | 61 | 1 years | |
| Johannes G. C. P. Schikan | M | 66 | 3 years | |
| Eric Gunnar Daniel Persson | M | 52 |
University of Uppsala
| 4 years |
| Mats Gullberg | M | 53 |
University of Uppsala
| 5 years |
| Andrew Kay | M | 69 | - | |
| Dina Chaya | M | 52 | 3 years | |
| Peder Sven Walberg | M | 50 | 3 years | |
| Mats Bo Johan Nilsson Bernitz | M | 54 |
University of Uppsala
| 3 years |
| Genghis Lloyd-Harris | M | 67 | - | |
| Björn Henriksson | M | - |
University of Uppsala
| 13 years |
| Therese Moberg | F | - |
Stockholm School of Economics
| 5 years |
| Tove Larsson | F | - |
Stockholm School of Economics
| 5 years |
| Victor Kihlgren | M | - |
Stockholm School of Economics
| 3 years |
| Mikhail Valeryevich Polunin | M | 49 |
Stockholm School of Economics
| 2 years |
| Oleksandr Komarov | M | 51 |
Stockholm School of Economics
| 2 years |
| Sara Wedin | F | - |
Stockholm School of Economics
| 4 years |
| Kalle Björklund | M | - |
Stockholm School of Economics
| 3 years |
| Christoffer Norman | M | - |
Stockholm School of Economics
| 3 years |
| Bruno Urquidi | M | - |
Stockholm School of Economics
| - |
| Douglas Martinsson | M | - |
Stockholm School of Economics
| 3 years |
| Jesper Hofstedt | M | - |
Stockholm School of Economics
| 12 years |
| Lave Beck-Friis | M | - |
Stockholm School of Economics
| 3 years |
| David Kuritzén | M | - |
Stockholm School of Economics
| 3 years |
| Olof Sandberg | M | - |
Stockholm School of Economics
| 2 years |
| Erik Dansbo | M | 44 |
Stockholm School of Economics
| 5 years |
| Staffan Unge | M | - |
Stockholm School of Economics
| 2 years |
| Janis Viba | M | - |
Stockholm School of Economics
| 4 years |
| Vita Cirjevska | F | - |
Stockholm School of Economics
| 4 years |
| Ebba Sjögren | F | - |
Stockholm School of Economics
| 3 years |
| Jonas Ahlgren | M | - |
Stockholm School of Economics
| 4 years |
| Louise Hagen | F | - |
Stockholm School of Economics
| 5 years |
| Gustav Segerberg | M | 42 |
Stockholm School of Economics
| 2 years |
| Alexandra Björklund | F | - |
Stockholm School of Economics
| 5 years |
| Hampus Nestius | M | - |
Stockholm School of Economics
| 4 years |
| Sara Damberg | F | - |
Stockholm School of Economics
| 3 years |
| Nordlund Jonas | M | - |
Stockholm School of Economics
| 2 years |
| Anders Berger | M | - |
Stockholm School of Economics
| 4 years |
| Pär Roosvall | M | 48 |
Stockholm School of Economics
| 2 years |
| Daniel Ahlstrand | M | 42 |
Stockholm School of Economics
| 5 years |
| Michael Raldow | M | - |
Stockholm School of Economics
| 6 years |
| Claes Magnus Jacob Ressel | M | - |
Stockholm School of Economics
| 4 years |
| Anna Maria Inga Söderblom | M | 60 |
Stockholm School of Economics
| 3 years |
| Sebastian Marcin Siemiatkowski | M | 43 |
Stockholm School of Economics
| 2 years |
| Johanna Svensson | F | - |
Stockholm School of Economics
| 2 years |
| Anders Hillerborg | M | 42 |
Stockholm School of Economics
| 4 years |
| Outi-Maria Liedes | F | 68 |
Stockholm School of Economics
| 3 years |
| Jenny Normark Sperens | F | 49 |
Stockholm School of Economics
| 2 years |
| Erik Hallert | M | - |
Stockholm School of Economics
| 3 years |
| Valery Murgulets | M | 47 |
Stockholm School of Economics
| 1 years |
| Petra Elväng | F | - |
Stockholm School of Economics
| 5 years |
| Martin Nilsson Erleman | M | 41 |
Stockholm School of Economics
| 4 years |
| Magnus Grufman | M | - |
Stockholm School of Economics
| 4 years |
| Alexey Nikolaevich Grom | M | 53 |
Stockholm School of Economics
| 2 years |
| Niklas Arne Ringby | M | 44 |
Stockholm School of Economics
| 4 years |
| Johan Lundén | M | - |
Stockholm School of Economics
| 4 years |
| Anders Mattias Letmark | M | 45 |
Stockholm School of Economics
| 5 years |
| Johan Carl Lundberg | M | 47 |
Stockholm School of Economics
| 2 years |
| Daniel Schuss | M | - |
Stockholm School of Economics
| 3 years |
| Adrian Imreorow | M | - |
Stockholm School of Economics
| 4 years |
| Ali Farahani | M | - |
Stockholm School of Economics
| 3 years |
| Filip Göran Bredinger | M | - |
Stockholm School of Economics
| 4 years |
| Oscar Claeson | M | - |
Stockholm School of Economics
| 5 years |
| Oleg Georgievich Davidovich | M | 55 |
Stockholm School of Economics
| 4 years |
| Henrik Geijer | M | - |
Stockholm School of Economics
| 3 years |
| Elise Fahlén | F | - |
Stockholm School of Economics
| 5 years |
| Daniel Thorsson | M | - |
Stockholm School of Economics
| 4 years |
| Sigrun Ingrid Hjelmquist | F | 68 |
Stockholm School of Economics
| - |
| Sanna Westman | F | - |
Stockholm School of Economics
| 3 years |
| Tommy Torwald | M | - |
Stockholm School of Economics
| 3 years |
| Per Agebäck | M | - |
Stockholm School of Economics
| 4 years |
| Björn Åke Theodor Beckman | M | 38 |
Stockholm School of Economics
| 3 years |
| Agnes Svensson | F | - |
Stockholm School of Economics
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 99 | 99.00% |
| Switzerland | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonas Karl Hansson
- Personal Network
